Pfizer Inc.

NYSE:PFE   1:53:37 PM EDT
42.97
-0.60 (-1.38%)
Products

U.S. FDA Approves Ticovac, Pfizer's Tick-Borne Encephalitis (TBE) Vaccine

Published: 08/14/2021 00:29 GMT
Pfizer Inc. (PFE) - U.S. FDA Approves Ticovac, Pfizer’s Tick-borne Encephalitis (tbe) Vaccine.
Studies Demonstrated That Ticovac Was Generally Well-tolerated With No Unexpected Adverse Events,vaccine-related Serious Adverse Events Observed.
U.S. Cdc Advisory Committee on Immunization Practices (acip) is Expected to Discuss Recommendations on Safe and Appropriate Use of Ticovac.